title: A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.
authors: Department of Medicine, Luzerner Kantonsspital, Luzern, Switzerland. oliver.gautschi@luks.ch
authors: Oliver
authors: O
authors: Gautschi
authors: Chantal
authors: C
authors: Pauli
authors: Klaus
authors: K
authors: Strobel
authors: Astrid
authors: A
authors: Hirschmann
authors: Gert
authors: G
authors: Printzen
authors: Stefan
authors: S
authors: Aebi
authors: Joachim
authors: J
authors: Diebold
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D000369:Aged, 80 and over; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D009154:Mutation / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D013449:Sulfonamides / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf